LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.56234
 24.09 27.76 37 1461 0.0253 0.0515
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 24.09 27.76 1217 1461 0.8326 0.9370
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 25.79 27.76 128 1605 0.0797 0.2984
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 25.79 27.76 1107 1605 0.6897 0.8770
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 25.79 27.76 43 1605 0.0268 0.0776
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 25.79 27.76 1227 1605 0.7644 0.9103
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 27.49 27.76 172 1723 0.0998 0.3583
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 27.49 27.76 1155 1723 0.6703 0.8701
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 27.49 27.76 51 1723 0.0296 0.1075
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 27.49 27.76 1254 1723 0.7277 0.8961
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 29.19 27.76 178 1863 0.0955 0.3583
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 29.19 27.76 1181 1863 0.6339 0.8553
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 29.19 27.76 70 1863 0.0376 0.1646
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 29.19 27.76 1321 1863 0.7090 0.8898
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 30.90 27.76 204 2032 0.1004 0.3799
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 30.90 27.76 1260 2032 0.6200 0.8514
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 30.90 27.76 77 2032 0.0379 0.1791
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 30.90 27.76 1368 2032 0.6731 0.8762
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 32.60 27.76 228 2235 0.1020 0.3946
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 32.60 27.76 1290 2235 0.5770 0.8336
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 32.60 27.76 82 2235 0.0367 0.1866
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 32.60 27.76 1406 2235 0.6288 0.8587
MN20160318_Q01
L15
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.30 27.76 242 2449 0.0988 0.3980
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.30 27.76 1358 2449 0.5543 0.8255
MN20160318_Q01
J22
MCF 10A-H2B-mCherry Dasatinib
0.56234
 34.30 27.76 103 2449 0.0420 0.2249
MN20160318_Q01
L15